Galileo Life Sciences, Inc. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/15c8424b-dffd-4b42-a884-b8dc3aac69ca/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-248.2k | 2013-07-01 – 2014-06-30 | evidence 0001199835-16-000710 |
| FY 2013 | $-648.4k | 2007-12-19 – 2014-03-31 | evidence 0001471242-14-000287 |
| FY 2012 | $-544.5k | 2007-12-19 – 2013-03-31 | evidence 0001144204-13-030388 |
| FY 2011 | $-503.3k | 2007-12-20 – 2012-03-31 | evidence 0001144204-12-030562 |
| FY 2010 | $-8.8k | 2009-07-01 – 2010-06-30 | evidence 0001144204-11-068656 |
| FY 2009 | $-661 | 2008-07-01 – 2009-06-30 | evidence 0001144204-11-068656 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Galileo Life Sciences, Inc. — all facts · Revenue · Operating Income